Literature DB >> 3190520

The degradation of type I collagen and human plasma fibronectin by the trypsin-like enzyme and extracellular membrane vesicles of Bacteroides gingivalis W50.

J W Smalley1, A J Birss, C A Shuttleworth.   

Abstract

A soluble trypsin-like enzyme (STE) was purified from a cell- and particle-free culture supernatant of this bacterium by a combination of ultra-centrifugation, ammonium-sulphate precipitation and gel-filtration chromatography on Sephacryl S-200. Trypsin-like activity in the culture supernatant was associated with a 58 kDa peptide and also with a higher molecular-weight complex. The STE and extracellular vesicle (ECV) fraction of B. gingivalis W50 rapidly degraded human plasma fibronectin in the presence and the absence of 10 mM dithiothreitol (DTT). The STE yielded a range of lower molecular-weight fibronectin digestion products. Under conditions where little activity was expressed by mammalian trypsin, both STE and ECV depolymerized a denatured and a native type I collagen substrate. Quantitative and qualitative differences were observed in the patterns of digestion products generated by both STE and ECV fraction following incubation with and without 10mM DTT. Inclusion of DTT appeared to reduce the degradative effect of both ECV and STE towards the type I collagen and plasma fibronectin substrates.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190520     DOI: 10.1016/0003-9969(88)90065-9

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  21 in total

1.  Inducible expression of a Porphyromonas gingivalis W83 membrane-associated protease.

Authors:  Y Park; B Lu; C Mazur; B C McBride
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Expression of Arg-Gingipain RgpB is required for correct glycosylation and stability of monomeric Arg-gingipain RgpA from Porphyromonas gingivalis W50.

Authors:  Minnie Rangarajan; Ahmed Hashim; Joseph Aduse-Opoku; Nikolay Paramonov; Elizabeth F Hounsell; Michael A Curtis
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Characterization of the tpr gene product and isolation of a specific protease-deficient mutant of Porphyromonas gingivalis W83.

Authors:  Y Park; B C McBride
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

Review 4.  Bacterial invasion of epithelial cells and spreading in periodontal tissue.

Authors:  Gena D Tribble; Richard J Lamont
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

5.  Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins.

Authors:  M Kontani; H Ono; H Shibata; Y Okamura; T Tanaka; T Fujiwara; S Kimura; S Hamada
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

6.  Cleavage of human transferrin by Porphyromonas gingivalis gingipains promotes growth and formation of hydroxyl radicals.

Authors:  Véronique Goulet; Bradley Britigan; Koji Nakayama; Daniel Grenier
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  In vitro models of tissue penetration and destruction by Porphyromonas gingivalis.

Authors:  Elisoa Andrian; Daniel Grenier; Mahmoud Rouabhia
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Isolation and characterization of the Porphyromonas gingivalis prtT gene, coding for protease activity.

Authors:  J Otogoto; H K Kuramitsu
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

9.  The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain.

Authors:  J Potempa; R Pike; J Travis
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Purification and characterization of two forms of a high-molecular-weight cysteine proteinase (porphypain) from Porphyromonas gingivalis.

Authors:  P Ciborowski; M Nishikata; R D Allen; M S Lantz
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.